Background: Growing evidence shows neurovascular dysfunction occurs early in Alzheimer's disease (AD) and may be a useful early marker of pathology. Blood-brain barrier water exchange rate (BBB kw) is a novel measure of fluid transport through the neurovascular unit. Lower BBB kw has been associated with vascular risk factors, but its relationship with age, vascular brain health and biomarkers of AD remains equivocal. The present study investigated the relationships between BBB kw, age, MRI measures of neurovascular integrity, and cerebrospinal fluid amyloid-beta (Aβ).

Method: The Brain and Cognitive Health (BACH) Cohort Study recruited 108 participants without dementia, aged 55-80 (68.5% female; mean age=67 years) from the general community. Participants underwent a suite of MRI scans (3T Siemens Prisma) that allowed for quantification of BBB kw, enlarged perivascular space volume (ePVS), diffusion free water (FW), cerebral blood flow (CBF), and white matter hyperintensity volume (WMH). A subsample of 35 individuals also completed an optional lumbar puncture for Aβ and Aβ quantification. Linear regression models and linear mixed-effects models were used to investigate the association between BBB kw and the outcomes. We also investigated whether there was an interaction effect of age on MRI measure relationships. All analyses were adjusted for age, sex and intracranial volume.

Result: BBB kw was negatively associated with age (B(SE)=-44.74(20.91), R =.04, p=.04), negatively associated with FW (B(SE)=-87.86(29.03), R =.128, p=.006; Figure 1), and positively associated with CBF (B(SE)=0.02(0.08), R =.128, p=.018; Figure 2). BBB kw was not associated with ePVS or WMH (p>.05). The association between BBB kw and CBF was modified by age (R =.06, p=.047), such that the relationship was stronger in younger participants (Figure 3). BBB kw was not associated with Aβ/Aβ ratio (B(SE)=59.89(205.30), R =<.01, p=.773) in the small subsample.

Conclusion: Lower efficiency of fluid transport through the neurovascular unit was associated with markers of neurovascular health, including cerebral perfusion and fluid accumulation/white matter integrity. These findings suggest BBB kw as a useful imaging tool for studying neurovascular unit integrity in the context of brain aging. Associations of BBB kw across the continuum of AD requires further investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.091069DOI Listing

Publication Analysis

Top Keywords

bbb associated
12
bbb
9
age mri
8
association bbb
8
negatively associated
8
figure bbb
8
associated
6
age
6
biomarkers background
4
background growing
4

Similar Publications

Advancing brain immunotherapy through functional nanomaterials.

Drug Deliv Transl Res

January 2025

Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, 300044, Hsinchu, Taiwan.

Glioblastoma (GBM), a highly aggressive brain tumor, poses significant treatment challenges due to its highly immunosuppressive microenvironment and the brain immune privilege. Immunotherapy activating the immune system and T lymphocyte infiltration holds great promise against GBM. However, the brain's low immunogenicity and the difficulty of crossing the blood-brain barrier (BBB) hinder therapeutic efficacy.

View Article and Find Full Text PDF

Pterostilbene protects against lipopolysaccharide-induced inflammation and blood-brain barrier disruption in immortalized brain endothelial cell lines in vitro.

Sci Rep

January 2025

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.

Brain microvascular endothelial cells are connected by tight junction (TJ) proteins and interacted by adhesion molecules, which participate in the selective permeability of the blood-brain barrier (BBB). The disruption of BBB is associated with the progression of cerebral diseases. Pterostilbene is a natural compound found in blueberries and grapes with a wide range of biological activities, including anti-inflammatory, antioxidant, and anti-diabetic effects.

View Article and Find Full Text PDF

Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration.

Int J Pharm

January 2025

Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran; Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, Canada; Centre for Biotechnology and Bioengineering (CBB), University of Waterloo, Waterloo, Canada; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada; Centre for Sustainable Business, International Business University, Toronto, Canada. Electronic address:

The blood-brain barrier (BBB) plays a vital role in protecting the central nervous system (CNS) by preventing the entry of harmful pathogens from the bloodstream. However, this barrier also presents a significant obstacle when it comes to delivering drugs for the treatment of neurodegenerative diseases and brain cancer. Recent breakthroughs in nanotechnology have paved the way for the creation of a wide range of nanoparticles (NPs) that can serve as carriers for diagnosis and therapy.

View Article and Find Full Text PDF

Nose-to-brain delivery of DHA-loaded nanoemulsions: A promising approach against Alzheimer's disease.

Int J Pharm

January 2025

MMDN, University of Montpellier, EPHE, INSERM, Montpellier, France; LipSTIC LabEx (ANR-11-LABX0021), Dijon, France. Electronic address:

Reduced docosahexaenoic acid (DHA) concentrations seem to be associated with an increased risk of Alzheimer's disease (AD), and DHA accretion to the brain across the blood-brain-barrier (BBB) can be modulated by various factors. Therefore, there is an urgent need to identify an efficient and non-invasive method to ensure brain DHA enrichment. In the present study, a safe and stable DHA-enriched nanoemulsion, designed to protect DHA against oxidation, was designed and administered intranasally in a transgenic mouse model of AD, the J20 mice.

View Article and Find Full Text PDF

Background: Post-COVID cognitive dysfunctions, impacting attention, memory, and learning, might be linked to inflammation-induced blood-brain barrier (BBB) impairment. This study explores post-COVID BBB permeability changes using a non-contrast water-exchange based MRI and their associations with blood Alzheimer's biomarkers.

Method: Sixty-seven participants were classified based on COVID (COV) and cognitive (COG) statuses into three groups: COV+/COG- (n=34), COV+/COG+ (n=23), and COV- (n=10) for comparisons (COV+: Laboratory-verified SARS-CoV-2 infection; COV-: No history of SARS-CoV-2 infection and negative SARS-CoV-2 nucleocapsid antibody test.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!